Are High Doses of Prednisone Necessary for Treatment of Interstitial Lung Disease in Systemic Sclerosis? Dionisio Pérez Campos, Miguel Estévez Del Toro, Aisa Peña Casanovas, Pedro Pablo González Rojas, Lisvenia Morales Sánchez, Ángela Rosa Gutiérrez Rojas

SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 2: Treatment Javier Narváez, Petra Díaz del Campo Fontecha, Noé Brito García, Gema Bonilla, Myriam Aburto, Iván Castellví, Esteban Cano-Jiménez, Natalia Mena-Vázquez, M. Asunción Nieto, Ana María Ortiz, Claudia Valenzuela, Miguel Ángel Abad Hernández, Isabel Castrejón, María Correyero Plaza, Félix Manuel Francisco Hernández, María Vanesa Hernández Hernández, José Antonio Rodríquez Portal

Subclinical interstitial lung disease in patients with systemic sclerosis. A pilot study on the role of ultrasound Samuel Reyes-Long, Marwin Gutierrez, Denise Clavijo-Cornejo, Alfonso Alfaro-Rodríguez, Karen González-Sámano, José Luis Cortes-Altamirano, Roberto Muñoz-Louis, Esteban Cruz-Arenas, Katia Camargo, Fernanda Gonzalez, Chiara Bertolazzi